Il mercato dell’immunoistochimica crescerà a un CAGR del 7,4% per raggiungere 3.585,31 milioni di dollari dal 2021 al 2028

  • Report Code : TIPRE00006184
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 259
Buy Now

[Rapporto di ricerca] Si prevede che il mercato dell'immunoistochimica raggiungerà i 3.585,31 milioni di dollari entro il 2028 dai 2.171,61 milioni di dollari del 2021; si stima registrerà un CAGR del 7,4% dal 2021 al 2028.

Approfondimenti di mercato e vista degli analisti:< /u>

L'immunoistochimica (IHC) è uno strumento utilizzato con tecniche basate sulla microscopia per osservare componenti cellulari come proteine o altre macromolecole in un campione di tessuto. È uno strumento utilizzato abitualmente in assistenza sanitaria e patologia. L'IHC è ampiamente utilizzato nelle applicazioni di ricerca in cui le molecole di interesse vengono analizzate per studiare il loro ruolo nelle cellule e nei tessuti sia sani che malati a livello cellulare, molecolare o tissutale. Esistono numerosi metodi IHC che possono essere utilizzati per localizzare gli antigeni. Parametri come i tipi di campione e la sensibilità del test sono considerati principalmente nell'IHC. Si prevede che la dimensione globale del mercato IHC dell'immunoistochimica raggiungerà 3.585,31 milioni di dollari nel 2028 da 2.1716,1 milioni di dollari nel 2021. Si stima che il mercato crescerà con un CAGR del 7,4% dal 2021 al 2028.

Fattori e sfide della crescita:

Crescente incidenza di malattie croniche e malattie infettive

L'immunoistochimica (IHC) si riferisce a un'importante applicazione di anticorpi monoclonali e policlonali per la determinazione tissutale e la distribuzione di antigeni di particolari malattie. Viene utilizzato principalmente per rilevare diversi disturbi infettivi come la dengue, l'epatite, il virus dell'immunodeficienza umana (HIV). Anche le condizioni mediche croniche come l'obesità, il cancro, il diabete, le malattie cardiache e l'ictus sono considerate le principali applicazioni dell'immunoistochimica che aiutano nella diagnosi di queste malattie.

Secondo il Programma congiunto delle Nazioni Unite sull'HIV/AIDS (UNAIDS), nel 2020 c'erano circa 37,6 milioni di persone in tutto il mondo affette da HIV. Di questi, 35,9 milioni erano adulti e 1,7 milioni erano bambini (

Restrizioni del mercato

Limitazioni associate all'immunoistochimica< /u>

L'immunoistochimica utilizza la specificità degli anticorpi per rilevare molecole bersaglio tra i tessuti o le cellule. Inoltre, l'IHC ha dimostrato di essere una tecnica potente anche nella tossicologia investigativa. Tuttavia, alcune limitazioni associate alla specificità e all'accuratezza della tecnica ne limitano l'adozione a un certo livello.

La mancanza di specificità dei reagenti è un problema più comune di è generalmente riconosciuto. La mancanza di specificità può comportare un enorme spreco in termini di risorse e tempo. Inoltre, l'applicazione della tecnica è limitata anche dalle limitazioni fisiche degli anticorpi. Inoltre, l'immunoistochimica può essere fuorviante se il disegno dello studio di colorazione non è attentamente concepito e controllato.

Sebbene questo sistema sia il metodo più semplice e conveniente per il rilevamento di una determinata espressione di marcatore , non è impiegato efficacemente in applicazioni cliniche e di ricerca a causa di limitazioni quali sensibilità insufficiente, necessità di coniugare individualmente ciascun anticorpo primario con fluorofori o enzimi e problemi di colorazione. Pertanto, le limitazioni associate alla tecnica IHC possono ostacolare la crescita del mercato in una certa misura.

Segmentazione e ambito del rapporto:

Il “mercato globale dell'immunoistochimica” è segmentato in base all'applicazione, al prodotto, all'utente finale e all'area geografica. Il mercato globale dell’immunoistochimica, basato sui prodotti, è stato segmentato in anticorpi, apparecchiature, reagenti e kit. Il mercato globale dell’immunoistochimica, basato sull’applicazione, è segmentato in diagnostica e test farmacologici. Nel 2021, il segmento della diagnostica deterrà probabilmente la quota maggiore del mercato. Il mercato globale dell'immunoistochimica, in base all'utente finale, è stato segmentato in ospedali e amp; laboratori diagnostici, istituti di ricerca e altri. Il mercato dell’immunoistochimica, in base alla geografia, è segmentato in Nord America (Stati Uniti, Canada e Messico), Europa (Germania, Francia, Italia, Regno Unito, Russia e resto d’Europa), Asia Pacifico (Australia, Cina, Giappone, India, Corea del Sud e resto dell'Asia Pacifico), Medio Oriente e altri paesi. Africa (Sudafrica, Arabia Saudita, Emirati Arabi Uniti e resto del Medio Oriente e dell'Africa) e Sud e Africa. America centrale (Brasile, Argentina e resto dell'America meridionale e centrale)

Analisi segmentale:

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which is the most influencing segment growing in the immunohistochemistry market report??

Antibodies is the most influencing segment growing in the immunohistochemistry market.

What are the opportunities for new immunohistochemistry market entrants?

Development opportunities in emerging countries are likely to fuel the market growth in the comping years.

What are the key trends in the immunohistochemistry market?

Increasing acceptance of automation in immunohistochemistry is likely to act as trend the market growth in the comping years.

Which are the key players in the immunohistochemistry market?

Key players in the market are F. Hoffmann-LA Roche AG, Merck KGaA, PerkinElmer, Inc., Thermo Fisher Scientific, Inc., Abcam Plc, Agilent Technologies, Bio SB, Bio-Rad Laboratories, Cell Signaling Technology, Inc., and Danaher Corporation among others.

What are the driving factors for the immunohistochemistry market across the globe?

Key factors driving the growth of the market are rising incidences of chronic and infectious diseases, increasing geriatric population, and increasing R&D investments by biotechnology & biopharmaceutical companies are among the key factors driving the market.

What is Immunohistochemistry?

Immunohistochemistry is a tool used microscopy-based techniques to observe cellular components such as proteins or other macromolecules in a tissue sample. It is routinely used tool in health care and pathology. IHC is widely used in research application where molecules of interest are analyzed to study their roles in both healthy and diseased cells and tissues on the cellular, molecular, or tissue level. There are numerous IHC methods that can be used to localize antigens. Parameters like specimen types and assay sensitivity are majorly considered in IHC.

Which region is lucrative for the immunohistochemistry market?

Asia-Pacific is the lucrative for the immunohistochemistry market.

The List of Companies - Immunohistochemistry Market

  1. F. Hoffmann-LA Roche AG
  2. Merck KGaA
  3. PerkinElmer, Inc.
  4. Thermo Fisher Scientific, Inc.
  5. Abcam Plc
  6. Agilent Technologies
  7. Bio SB
  8. Bio-Rad Laboratories
  9. Cell Signaling Technology, Inc.
  10. Danaher Corporation

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports